Aynur Işık

Biochemistry, Genetics and Molecular BiologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer”.

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

Cell Death and Disease(2024)10.1038/s41419-024-06814-3

N/A

0.804DataRank · unranked

31 citations

Rashedul Alam, Kim‐Tuyen Huynh‐Dam, Aynur Işık, Meral Üner, Nevin Belder +17 more

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Nature Communications(2020)10.1038/s41467-020-16199-4

N/A

0DataRank · unranked

370 citations

Aysegül Kaymak, Umar Raza, Pelin G. Ersan, Özge Akbulut, Carolyn E. Banister +18 more

Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.05.565697

N/A

0DataRank · unranked

2 citations

R. T. M. Alam, Kim‐Tuyen Huynh‐Dam, Aynur Işık, Meral Üner, Nevin Belder +15 more